InvestorsHub Logo
Followers 32
Posts 12668
Boards Moderated 0
Alias Born 08/29/2012

Re: kayak_wench post# 385764

Tuesday, 08/22/2023 3:47:14 PM

Tuesday, August 22, 2023 3:47:14 PM

Post# of 402169
I'm surprised people don't know that Elite failed their Generic Concerta BE study a few years ago.

In the CC either 2 or 3 years ago, I think it was a February CC, Nasrat said the CNS product that we got from SunGen(now Praxgen) was in a BE study and the results were expected in a few months.

They never came.....

They've been working on getting Generic Concerta approved since 2019 or 2020 when Elite fully took back the product from SunGen(now Praxgen).

They can't figure it out.

I would assume Generic Vyvanse is just if not more complicated to development.

We know the BE study that was just completed last week was one of these two products.

Can you recall a BE that Nasrat talked about that didn't come to fruition?


MAKE ELITE GREAT AGAIN!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News